Cargando…
Resectable adenocarcinoma developing in the remnant pancreas 7 years after partial pancreatoduodenectomy for invasive ductal adenocarcinoma of the pancreas: a case report
BACKGROUND: Pancreatic adenocarcinoma still has an excessively high mortality rate and resection is the only potentially curative treatment. The postoperative 5-year survival rate is approximately 20% and recurrence develops generally within 2 years. We report a case of a localized recurrent pancrea...
Autores principales: | Frei, Lina, Stieger, Ruedi, Bayerl, Christian, Breitenstein, Stefan, Staerkle, Ralph F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513331/ https://www.ncbi.nlm.nih.gov/pubmed/28716115 http://dx.doi.org/10.1186/s13256-017-1359-3 |
Ejemplares similares
-
A resected case of recurrent ITPN in the remnant pancreas after pancreatoduodenectomy
por: Ko, Kenju, et al.
Publicado: (2019) -
Functional and morphological evolution of remnant pancreas after resection for pancreatic adenocarcinoma
por: Park, Shin-Young, et al.
Publicado: (2017) -
Pylorus Preserving Pancreatoduodenectomy Versus Whipple Procedure
for Adenocarcinoma of The Head of The Pancreas
por: Belli, Lino, et al.
Publicado: (1989) -
Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion
por: Oba, A., et al.
Publicado: (2020) -
Resectable carcinoma developing in the remnant pancreas 7 years and 10 months after distal pancreatectomy for invasive ductal carcinoma of the pancreas: report of a case
por: Akabori, Hiroya, et al.
Publicado: (2014)